Publication
Article
Pharmacy Times
A survey of 500 adults with rheumatoidarthritis (RA) revealed that 70% ofthe patients still experience unbearablepain, stiffness, and fatigue daily. Morethan one third rank their quality of lifeat only 5 out of 10 at best.
The survey, a collaboration betweenthe Arthritis Foundation and HarrisInteractive Inc, showed that half of therespondents' symptoms were reducedby medication.
Yet, 49% reported that they continueto modify their daily household activitiesbecause of their arthritis. Amongthe survey's other findings were thefollowing:
• More than two thirds of RApatients receiving disease-modifyingantirheumatic drugs (DMARDs) or biologicresponse modifiers (BRMs) stillexperience pain (70% and 71%, respectively),stiffness (69% and 75%), andfatigue (67% and 67%) daily, despitecurrent medication use
• The 3 main concerns amongpatients who have been prescribed currenttreatments for RA (DMARDs,BRMs) are the potential for long-termhealth consequences (42% and 45%),an increased risk of infection (36% and41%), and less than adequate relieffrom fatigue (34% and 32%)
• All of the respondents would beinterested in new RA treatments thatease pain more completely or providelonger periods of relief from pain
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.